disulfiram has been researched along with Leishmaniasis in 1 studies
Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Namazi, MR | 1 |
1 other study available for disulfiram and Leishmaniasis
| Article | Year |
|---|---|
Potantial utility of disulfiram against leishmaniasis.
Topics: Adjuvants, Immunologic; Animals; ATP Binding Cassette Transporter, Subfamily B; Chelating Agents; Di | 2008 |